文献速递系统性红斑狼疮

英国多种族队列中300例系统性红斑狼疮患者长期随访的损伤累积与死亡

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究回顾性分析了伦敦300例系统性红斑狼疮(SLE)患者长达40年(中位13.3年)的随访资料,发现77%的患者出现不可逆损伤,且损伤随时间线性累积;非洲/加勒比裔、肾脏及脑受累、早期使用大剂量激素或免疫抑制剂、抗RNP及抗磷脂抗体与损伤相关,损伤与死亡强相关。

要点

  • SLE患者损伤累积率达77%,且随随访时间线性增加。
  • 非洲/加勒比裔、肾脏/脑受累、早期大剂量激素或免疫抑制剂、抗RNP及抗磷脂抗体与损伤相关。
  • 损伤与死亡强相关:死亡患者中93%存在损伤,存活者中为70%(P<0.001)。

核心结论

  • SLE患者损伤累积与死亡风险增加强相关,且识别出包括早期使用大剂量激素和免疫抑制剂在内的损伤高危群体。

研究设计与样本

  • 回顾性分析英国伦敦300例SLE患者病历及SDI评分,随访至多40年(中位13.3年),采用单变量和多变量分析比较组间特征,Kaplan-Meier分析死亡及损伤累积影响因素。

主要发现

  • 300例中231例(77%)出现损伤,损伤在40年随访中呈线性累积。
  • 与损伤相关的因素包括非洲/加勒比裔、肾脏和脑受累、早期使用大剂量皮质类固醇或免疫抑制剂、抗RNP抗体及抗磷脂抗体。
  • 87例死亡患者中93%存在损伤,存活者中损伤比例为70%(P<0.001)。

临床怎么用

  • 对具有非洲/加勒比裔背景、肾脏或脑受累、抗RNP或抗磷脂抗体阳性的SLE患者应加强损伤监测。
  • 早期使用大剂量激素或免疫抑制剂的患者属于损伤高危人群,需权衡治疗获益与损伤风险。

局限性

  • 回顾性分析设计可能存在信息偏倚。
  • 单中心多种族队列,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Damage in patients with systemic lupus erythematosus is irreversible change in organs due to disease activity, concomitant disease or medication side-effects. It is measured using the Systemic Lupus International Collaborative Clinics Damage Index (SDI) and is associated with increased mortality. Previous reports have suggested associations between damage accrual and various ethnic, disease and treatment factors, but there is a dearth of long-term follow-up data from large multi-ethnic cohorts. We describe a study of damage and mortality in 300 patients from London, UK followed for up to 40 years. METHODS: We carried out retrospective analysis of medical records and SDI scores of 300 patients followed for up to 40 years (median 13.3 years). Characteristics of the groups who did and did not develop damage and those who died or survived to the end of follow-up were compared using univariable and multivariable analysis. Kaplan-Meier analysis was used to analyse factors affecting mortality and accrual of damage. RESULTS: Damage developed in 231/300 (77%) of patients. There was a linear accrual of damage over 40 years follow-up. Factors associated with damage were African/Caribbean ethnicity, renal and cerebral involvement, early use of high-dose corticosteroids or immunosuppressants, anti-RNP and antiphospholipid antibodies. Damage was strongly associated with mortality. Of 87 patients who died, 93% had damage compared with 70% of survivors (P < 0.001). CONCLUSION: Development of damage is strongly associated with increased mortality. We identified groups at increased risk of developing damage, including those treated with high-dose steroids and immunosuppressants within the first two years.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Segura BT, Bernstein BS, McDonnell T, et al. Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort. Rheumatology (Oxford). 2020. PMID: 31377781. doi:10.1093/rheumatology/kez292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。